NET 11 Preview 4 delivers a broad set of developer-facing updates across .NET MAUI, ASP.NET Core, Blazor, Entity Framework Core, the SDK, libraries and runtime performance work.

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Modern .NET development should focus on current .NET rather than .NET Framework for long-term viability and platform flexibility. Performance gains come from deliberate tooling, code reviews, and ...

Millions of AI agents and tools around the world have been imperiled by a critical vulnerability that can allow hackers to ...

Indian benchmark indices rallied sharply on Monday, with the Nifty surging 312.40 points, or 1.32%, to close at 24,031.70, ...

IOWA CITY, Iowa (KCRG) - The Housing Authority of Iowa City is creating a nonprofit extension that could mean an additional half a million dollars a year for affordable housing efforts. The Housing ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

We moved away from an LLM-first approach and shifted toward a code-first architecture with bounded AI assistance.

Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...

The latest FanDuel promo code offers new users $150 in bonus bets when you bet at least $5. If your first bet wins (no odds limits), you'll receive $150 in bonus bets. Just click the CLAIM BONUS ...

Clinical stage company Evaxion Biotech is using artificial intelligence (AI) to simulate the immune system and create predictive models to identify novel targets for vaccines against bacterial and ...

Global Phase 3, randomized, controlled trial comparing azenosertib to standard-of-care chemotherapy now enrolling ASPENOVA designed as confirmatory study to support DENALI Phase 2 accelerated approval ...